← FDA DRUG APPROVALS

FDA ANDA · ANDA202573

RITONAVIR FILM COATED

ritonavir 100 mg

Sponsor: CIPLA

APPLICATION
ANDA202573
TYPE
ANDA
ORIGINAL APPROVAL
2015-01-15
LATEST ACTION
2021-12-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

RITONAVIRPrescription
RITONAVIR 100MG · TABLET · ORAL

Approval history

2021-12-22Labeling · Supplement 2 · standardAP
2021-12-22Labeling · Supplement 9 · standardAP
2021-12-22Labeling · Supplement 7 · standardAP
2021-12-22Labeling · Supplement 3 · standardAP
2021-12-22Labeling · Supplement 1 · standardAP
2021-12-22Labeling · Supplement 6 · standardAP
2021-12-22Labeling · Supplement 4 · standardAP
2015-01-15UNKNOWN · Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →